Sonic Healthcare (SHL) upgraded to Buy from Neutral by UBS (B/H/S: 4/4/0)

Sonic Healthcare (SHL) upgraded to Buy from Neutral by UBS (B/H/S: 4/4/0). UBS considers the risk of offshore reform is moderating and Australia's reform risk is contained. The broker observes the sovereign risk hung over Sonic for more than seven years in some form or another and the situation now deserves a review. Historically, the company's model delivers over 30% in incremental margin on new volume but this leverage has been reduced or diluted by unrelenting reforms and cuts. UBS is upgrading to Buy from Neutral on valuation grounds. The price target is raised to $19.00 from $18.00.


FNArena is a supplier of financial, business and economic news, analysis and data services.

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.